IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma
Authors
Keywords
-
Journal
Molecular Oncology
Volume 12, Issue 6, Pages 936-952
Publisher
Wiley
Online
2018-04-25
DOI
10.1002/1878-0261.12306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular insights into tumour metastasis: tracing the dominant events
- (2017) Ke Jin et al. JOURNAL OF PATHOLOGY
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulatingN6-methyladenosine-dependent primary MicroRNA processing
- (2016) Jin-zhao Ma et al. HEPATOLOGY
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling
- (2016) Laixi Bi et al. Journal of Translational Medicine
- The Role of Interleukin-17 in Lung Cancer
- (2016) Feng Wu et al. MEDIATORS OF INFLAMMATION
- Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition
- (2016) Q Zhang et al. ONCOGENE
- IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
- (2015) Jung-Ta Kao et al. BMC GASTROENTEROLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression
- (2015) T.-S. Chang et al. CLINICAL CANCER RESEARCH
- Th17 cytokines in non-melanoma skin cancer
- (2015) Florencia McAllister et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
- (2015) R H Prabhala et al. LEUKEMIA
- Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma
- (2015) Qi-fei Tao et al. Molecular Cancer
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest
- (2014) J.M. Wilson et al. JOURNAL OF SURGICAL RESEARCH
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
- (2013) Rui Liao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma
- (2013) Zhong-Hua Tao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
- (2012) Oscar H. Ocaña et al. CANCER CELL
- PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription
- (2012) Kaijie Wu et al. CELLULAR SIGNALLING
- TGF-β in Epithelial to Mesenchymal Transition and Metastasis of Liver Carcinoma
- (2012) Patrick Reichl et al. CURRENT PHARMACEUTICAL DESIGN
- Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
- (2012) Angela Gauthier et al. HEPATOLOGY RESEARCH
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
- (2012) Jianxiong Wu et al. PLoS One
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
- (2011) Fang-Ming Gu et al. Molecular Cancer
- Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression
- (2011) Jian Li et al. PLoS One
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
- (2009) Jing-Ping Zhang et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started